Premier Alternatives

Metagen Therapeutics

Tsuruoka, Japan · Founded 2020 · Privately Held (backing)

Operator of microbiome therapeutics and manufacturing platform intended to advance precision treatment using fecal microbiota transplantation. Metagen Therapeutics is based in Tsuruoka, Japan and was founded in 2020. Its last reported valuation was $54.2 million in Jan 2026. It has raised $36.5 million.

Last reported valuation
$54.2M
Oct 2026
Priced at
—
Total raised
$36.5M
Last round
—

Metagen Therapeutics key facts

as of Oct 2026
  • Operator of microbiome therapeutics and manufacturing platform intended to advance precision treatment using fecal microbiota transplantation.
  • Metagen Therapeutics is valued at approximately $54.2M as of Oct 2026 (last reported valuation).
  • It has raised $36.5M; the latest was Later Stage VC ($22.4M) in Jan 2026.
  • Notable investors include Global Brain, SMBC Venture Capital, Mizuho Capital, J-Startup, JIC Venture Growth Investments — 27 tracked in total.
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$54.2M

Metagen Therapeutics's last reported valuation, Jan 2026. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Metagen Therapeutics with a free account
  • ·The complete investor list: 27 names
  • ·Watch Metagen Therapeutics: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Metagen Therapeutics funding rounds

No rounds on record

No funding rounds for Metagen Therapeutics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.

Pro members can request priority coverage with a 48-hour turnaround.

Metagen Therapeutics valuation

Metagen Therapeutics's last reported valuation was $54.2 million in Jan 2026. No priced round, secondary trade or fund mark has surfaced since.

Metagen Therapeutics investors

27 investors are on record for Metagen Therapeutics, including Global Brain, SMBC Venture Capital, Mizuho Capital and J-Startup. By type, the record holds 8 venture capital firms and 1 hedge fund.

About Metagen Therapeutics

Operator of microbiome therapeutics and manufacturing platform intended to advance precision treatment using fecal microbiota transplantation. The company offers GMP-compliant manufacturing, paired metagenomic datasets, and AI-driven donor-recipient matching, enabling clinicians and biopharmaceutical researchers, to develop targeted microbiome-based therapies across multiple disease areas.

Sector
Healthcare
HQ
Tsuruoka, Japan
Founded
2020
Employees
50
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.